Gene · 1406
Papers1,885
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,885
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Retinitis Pigmentosa: Pathogenesis, Diagnostic Findings, and Treatment. | Cureus | 2023 | 38034182 | PubTator, text mining | PubMed |
| Four different gene-related cone-rod dystrophy: clinical and genetic findings in six Chinese families with diverse modes of inheritance. | Front Genet | 2023 | 38028590 | PubTator, text mining | PubMed |
| Continuous non-adherent culture promotes transdifferentiation of human adipose-derived stem cells into retinal lineage. | Open Life Sci | 2023 | 38027227 | PubTator, text mining | PubMed |
| Integrated multi-omics single cell atlas of the human retina. | Res Sq | 2023 | 38014002 | PubTator, text mining | PubMed |
| Application of patient-derived induced pluripotent stem cells and organoids in inherited retinal diseases. | Stem Cell Res Ther | 2023 | 38012786 | PubTator, text mining | PubMed |
| Single-cell multiomics of the human retina reveals hierarchical transcription factor collaboration in mediating cell type-specific effects of genetic variants on gene regulation. | Genome Biol | 2023 | 38012720 | PubTator, text mining | PubMed |
| Multimodal Ophthalmic Imaging in Spinocerebellar Ataxia Type 7. | Life (Basel) | 2023 | 38004309 | PubTator, text mining | PubMed |
| Recent Advances of Adipose-Tissue-Derived Mesenchymal Stem Cell-Based Therapy for Retinal Diseases. | J Clin Med | 2023 | 38002628 | PubTator, text mining | PubMed |
| Missense mutations in CRX homeodomain cause dominant retinopathies through two distinct mechanisms. | Elife | 2023 | 37963072 | PubTator, text mining | PubMed |
| Application of Electrophysiology in Non-Macular Inherited Retinal Dystrophies. | J Clin Med | 2023 | 37959417 | PubTator, text mining | PubMed |
| Targeted inhibition of Wnt signaling with a Clostridioides difficile toxin B fragment suppresses breast cancer tumor growth. | PLoS Biol | 2023 | 37943878 | PubTator, text mining | PubMed |
| Episodic live imaging of cone photoreceptor maturation in GNAT2-EGFP retinal organoids. | Dis Model Mech | 2023 | 37902188 | PubTator, text mining | PubMed |
| Occult Macular Dysfunction Syndrome: Identification of Multiple Pathologies in a Clinical Spectrum of Macular Dysfunction with Normal Fundus in East Asian Patients: EAOMD Report No. 5. | Genes (Basel) | 2023 | 37895218 | PubTator, text mining | PubMed |
| The New Era of Therapeutic Strategies for the Treatment of Retinitis Pigmentosa: A Narrative Review of Pathomolecular Mechanisms for the Development of Cell-Based Therapies. | Biomedicines | 2023 | 37893030 | PubTator, text mining | PubMed |
| Environmental allergen reduction in asthma management: an overview. | Front Allergy | 2023 | 37868650 | PubTator, text mining | PubMed |
| Reliability of human retina organoid generation from hiPSC-derived neuroepithelial cysts. | Front Cell Neurosci | 2023 | 37868194 | PubTator, text mining | PubMed |
| Role of ciliopathy protein TMEM107 in eye development: insights from a mouse model and retinal organoid. | Life Sci Alliance | 2023 | 37863656 | PubTator, text mining | PubMed |
| Pituitary stalk interruption syndrome: A case report. | Radiol Case Rep | 2023 | 37840890 | PubTator, text mining | PubMed |
| Biomaterials used for tissue engineering of barrier-forming cell monolayers in the eye. | Front Bioeng Biotechnol | 2023 | 37840667 | PubTator, text mining | PubMed |
| The Value of Electroretinography in Identifying Candidate Genes for Inherited Retinal Dystrophies: A Diagnostic Guide. | Diagnostics (Basel) | 2023 | 37835784 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1406/papers?page=7